dc.contributor.author | Aydin, S. | |
dc.contributor.author | Kuloglu, T. | |
dc.contributor.author | Aydin, Y. | |
dc.contributor.author | Yalcin, M. H. | |
dc.contributor.author | Ugur, K. | |
dc.contributor.author | Albayrak, S. | |
dc.contributor.author | Aksoy, A. | |
dc.contributor.author | Sahin, I. | |
dc.date.accessioned | 16/12/21 12:06 | |
dc.date.available | 16/12/21 12:06 | |
dc.date.issued | 2020 | |
dc.identifier.issn | 1052-0295 | |
dc.identifier.uri | http://dspace.beu.edu.tr:8080/xmlui/handle/20.500.12643/10081 | |
dc.identifier.uri | https://doi.org/10.1080/10520295.2019.1653497 | |
dc.description.abstract | Despite significant advances in medicine, mortality due to cardiovascular disease is not yet preventable. We investigated the amounts of elabela (ELA) and apelin, synthesized by cardiomyocytes, and changes of these compounds in cardiac tissue and circulat | |
dc.language.iso | English | |
dc.publisher | Taylor & Francıs Ltd | |
dc.source | Bıotechnıc & Hıstochemıstry | |
dc.title | Effects of iloprost and sildenafil treatment on elabela, apelin-13, nitric oxide, and total antioxidant and total oxidant status in experimental enzyme-positive acute coronary syndrome in rats | |
dc.type | Article | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 145 | |
dc.identifier.endpage | 151 | |
dc.identifier.doi | 10.1080/10520295.2019.1653497 | |
dc.identifier.wos | WOS:000482430100001 | |
dc.identifier.volume | 95 | |